Skip to content
WeighLab

Bon Health vs Layla

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Bon Health

Provider comparison

Shoppers who want compounded GLP-1s with physician-adjusted dosing, no membership fee, and a lower rate on longer commitments.

Semaglutide / month
$220/moMonth-to-month, compounded; $95/mo with $1,140 annual prepay
Tirzepatide / month
$285/moMonth-to-month, compounded; $135/mo with $1,620 annual prepay
Index 58/100 · Grade CChecked October 2026

Layla

Provider comparison

Shoppers who want brand-name Ozempic, Wegovy, Zepbound or Mounjaro with check-ins included and don't need a lower-cost compounded option.

Semaglutide / month
$1,399/moBrand Ozempic, promotional rate
Tirzepatide / month
$1,399/moBrand Mounjaro, promotional rate
Index 57/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Bon Health has the higher Cost-Efficiency Index: 58/100 versus 57/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Bon Health

Layla

Semaglutide / month
Bon Health: $220/moMonth-to-month, compounded; $95/mo with $1,140 annual prepay
Layla: $1,399/moBrand Ozempic, promotional rate
Tirzepatide / month
Bon Health: $285/moMonth-to-month, compounded; $135/mo with $1,620 annual prepay
Layla: $1,399/moBrand Mounjaro, promotional rate
Semaglutide / year (modeled)
Bon Health: $2,640
Layla: $16,788
Tirzepatide / year (modeled)
Bon Health: $3,420
Layla: $16,788
State availability
Bon Health: Coverage not published
Layla: Coverage not published
Oral / sublingual option listed
Bon Health: Not listed
Layla: Not listed
Brand-name access listed
Bon Health: Not confirmed
Layla: Yes
Provider facts checked
Bon Health: October 2026
Layla: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Bon Health

Shoppers who want compounded GLP-1s with physician-adjusted dosing, no membership fee, and a lower rate on longer commitments.

Reasons to consider it

  • Publishes monthly and prepaid prices for both compounded drugs
  • No separate membership fee; shipping and supplies included
  • Offers clinician review and ongoing messaging support

What to weigh up

  • Semaglutide $220 and tirzepatide $285 are month-to-month prices; advertised $95/$135 require $1,140/$1,620 paid annually
  • Quarterly and six-month plans also require advance payment for the whole term
  • Brand-name product pages remain marked coming soon rather than establishing current brand access

Layla

Shoppers who want brand-name Ozempic, Wegovy, Zepbound or Mounjaro with check-ins included and don't need a lower-cost compounded option.

Reasons to consider it

  • All-inclusive pricing bundles health check-ins, telehealth visits, prescription and unlimited doctor messaging into one price
  • Names its Medical Director (Dr. Ruth Cohen) on its site
  • LegitScript-certified badge displayed; fast 2-3 day shipping claimed

What to weigh up

  • Brand-only and expensive: the real floor is $1,399/mo (Ozempic/Mounjaro), not the $1,299 the homepage FAQ separately claims — the two figures don't reconcile
  • The lowest Zepbound figure shown ($1,599) is a one-time new-customer discount off a $1,699 standing price, not an ongoing rate
  • No compounded or lower-cost option on the current site, and states served are not published

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Bon HealthLayla
Normalized Cost/Month
Bon Health:
46/100
Layla:
41/100
Price Transparency
Bon Health:
78/100
Layla:
78/100
Nationwide Access
Bon Health:
24/100
Layla:
24/100
Formulation Options
Bon Health:
66/100
Layla:
79/100
Clinical Oversight
Bon Health:
86/100
Layla:
81/100
Contract Flexibility
Bon Health:
61/100
Layla:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.